Pharma/biotech giants Pfizer PFE and Bristol Myers BMY boast a dominant position in the lucrative oncology space. Oncology or ...

“These advancements are phenomenal,” said Biljana Naumovic, President, Solid Tumor, US Oncology at Johnson & Johnson Innovative Medicine. “But unless we get them to patients, then it really doesn’t ...

Because Oregon has weak lobbying disclosure and transparency rules, lobbyists are not required to inform clients nor obtain ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 23, 2025 /PRNewswire/ -- USA News GroupNews Commentary – Cancer diagnoses are climbing fastest among younger women, sparking alarm that ...

“Cancer patients and their families are being pulled into the insurance prior authorization process, at the expense of their ...

A private oncology shared savings plan reduced colon cancer treatment costs. Results varied by tumor, with none in breast cancer and mixed effects in lung cancer. Objectives: Participation in the ...

Tampa, Fla.-based Moffitt Cancer Center has launched a venture studio aimed at leveraging insights from health systems’ intellectual property — starting with Moffitt’s own — to develop “scalable ...

In June, Newport Beach, Calif.-based Hoag b e came the first hospital in the U.S. to offer EsoGuard testing. The test is used by physicians to detect precancerous DNA changes in esophageal cells, ...

More efforts are needed to advance diversity in research, including the study of factors enabling the success of bright spot trials. As these recent efforts take effect, it is critical to understand ...